More than 1,000 young females were screened for rubella HI antibodies. Clinico-laboratory studies were carried out in 272 seronegative healthy adult women who received Japanese licensed rubella vaccine, TO-336 or MEQ11 vaccine. Clinical reactions were observed in 51 (29.7%) of 172 vaccinees, aged 18-30 years (mean age; 20. 8 year), who received TO-336… (More)
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.